Driven by
Dynamism

Supporting healthcare through a forward-looking approach shaped by reliability, consistency and accessibility.

At Devatis New Zealand, we deliver reliable pharmaceutical solutions for the New Zealand healthcare system. With a dynamic, forward-looking approach, we respond to evolving healthcare needs in both regulated markets and growing economies.

Quality

Precision in Every Step

Our manufacturing facilities operate in line with US FDA and EU GMP standards, supporting a consistent approach to quality and safety. As an integrated and responsible pharmaceutical company, we work across the value chain, from raw materials to finished products, to support reliable supply, consistent availability, and on-time delivery.

"At Devatis New Zealand, we aim to support healthcare nationwide through reliable, high-quality pharmaceutical solutions shaped by excellence. Our focus on quality, safety, and professional collaboration enables us to meet the evolving needs of New Zealand’s healthcare system."

Philipp D. Haas
Philipp D. Haas
Chairman & CEO, Devatis
Read Full Message

Vision & Mission

Our Purpose

At Devatis, our purpose is clear: to deliver reliable pharmaceutical solutions through a structured and responsible approach.

We are committed to addressing the needs of patients and healthcare professionals in New Zealand. Through precision, consistency, and a focus on long-term value, we aim to support healthcare systems in a careful and sustainable way.

Our Core Principles

Excellence

We apply high standards across our operations, from development and manufacturing to global distribution, supporting consistency at every step.

Reliability

Consistency and trust shape our approach. We support reliable pharmaceutical supply through precision, continuity, and a structured way of working.

Dynamism

With a proactive mindset, we continuously evolve to meet the challenges of an ever-changing healthcare landscape.

A Story of Growth

Since our inception, Devatis has grown steadily, expanding its international footprint and establishing a reliable presence across global markets.
2007

New Zealand

DEVATIS LTD was established to market medicinal products for human use and veterinary drugs in New Zealand.

As a result of the tenders won under the DEVATIS LTD, our product portfolio in New Zealand continues to expand in various therapeutic areas.

Therapeutic Areas

  • Oncology and Hematology
  • Central Nervous System
  • Sensory Organs
  • Systemic Anti-Infectives
  • Systemic Hormonal Preparations
  • Cardiovascular System
  • Musculoskeletal System
  • Digestive System and Metabolism
Visit Website
2014

Germany

DEVATIS GmbH maintained positive growth with launches in respiratory and CNS therapy areas and also became market leader for 4 molecules in Germany.

Therapeutic Areas

  • Central Nervous System
  • Sensory Organs
  • Systemic Anti-Infectives
  • Systemic Hormonal Preparations
  • Cardiovascular System
  • Respiratory System
Visit Website
2015

USA

DEVATIS INC. is the U.S. entity of Devatis, delivering high-quality pharmaceuticals to the American market.
With a commitment to excellence in every dose, it ensures consistent quality, reliable supply, and value-added solutions.
DEVATIS INC. leverages state-of-the-art manufacturing facilities and a mature sales network to provide trusted products with on-time delivery and continuous availability across the U.S.

Therapeutic Areas

  • Oncology and Hematology
  • Sensory Organs
  • Systemic Anti-Infectives
  • Cardiovascular System
  • Musculoskeletal System
  • Respiratory System
Visit Website
2018

Switzerland

DEVATIS AG, launches its new products in Switzerland in various therapy areas, including cardiology, antibiotics, and antifungals, besides attends major congresses in oncology, hematology and nephrology. Additionally, as business development efforts persist in Europe, the position of its antifungal products in the market is strengthening, particularly in Italy.

Therapeutic Areas

  • Cardiovascular System
  • Central Nervous System
  • Oncology and Hematology
  • Systemic Hormonal Preparations
  • Systemic Anti-Infectives
  • Digestive System and Metabolism
  • Dermatology and Immunology
Visit Website
2019

Mexico

DEVATIS DE MEXICO, S.DE RL. DE C.V started its activities with its ophthalmology products in Mexico.
Ophthalmology portfolio is being made available to patients in the Mexican market, with the plan to establish the permanence of the DEVATIS DE MEXICO, S.DE RL. DE C.V brand in the country through the created structure.

Therapeutic Areas

  • Sensory Organs
Visit Website
2020

Australia

DEVATIS PTY LTD was established to market medicinal products for human use and veterinary drugs in Australia.
The development of potential strategic products is ongoing.

Therapeutic Areas

  • Central Nervous System
Visit Website
2020

Canada

DEVATIS CANADA INC. plans to strengthen its product portfolio in the country with the products in its pipeline, aiming to make the brand more active in the near future.
Visit Website
2023

Serbia

DEVATIS D.O.O. BEOGRAD, was established in 2023 to market medicinal products for human use and veterinary drugs in Serbia.
The development of potential strategic products is ongoing.
Visit Website
2024

Azerbaijan

DEVATIS MMC was established in 2024.

Therapeutic Areas

  • Oncology and Hematology
  • Respiratory System
  • Cardiopulmonary
  • Dermatology and Immunology
Visit Website
2024

Netherlands

DEVATIS B.V, was established in 2024 to market medicinal products for human use and veterinary drugs in the Netherlands.
The development of potential strategic products is ongoing.

Therapeutic Areas

  • Sensory Organs
  • Systemic Anti-Infectives
  • Dermatology and Immunology
Visit Website
2025

UK

DEVATIS UK LTD was established in 2025 as part of Devatis’s global expansion, bringing its high standards of pharmaceutical excellence to the United Kingdom.
With a focus on quality, trust, and consistent supply, DEVATIS UK LTD aims to contribute meaningfully to the UK healthcare system through value-added, internationally compliant pharmaceutical solutions.
Building on Devatis’s established global capabilities, the UK team is dedicated to delivering reliable medicines that meet the evolving needs of healthcare professionals across the country.
Visit Website
2025

Austria

DEVATIS GmbH is strengthening its presence in Europe with its entry into the Austrian market. Expanding our high-quality portfolio across various therapeutic areas, we continue to deliver excellence in every dose.

Therapeutic Areas

  • Central Nervous System
  • Oncology and Hematology
  • Dermatologie und Immunologie
Visit Website

Sustainability at Devatis New Zealand

At Devatis New Zealand, sustainability is at the heart of everything we do, guiding our efforts in protecting the environment, addressing public health needs, and driving innovation for a better tomorrow.

Environmental
Responsibility

From reducing our carbon footprint to adopting eco-friendly manufacturing practices, we are committed to protecting the planet while delivering excellence.

Growing Across Global Markets

Devatis continues to expand its presence across multiple regions, including Europe, North America, Asia, and Oceania. Guided by precision and reliability, we respond to evolving healthcare needs while strengthening our presence across global markets.

Explore Our Global Presence